Sangam: A Confluence of Knowledge Streams

Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial

Files in this item

Files Size Format View
advancesadv2020003010.pdf 1.017Mb application/pdf View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse